HCV NS3 inhibitors resistance mutations in the telaprevir started Turkish patients with chronic HCV

被引：0
|
作者：
Sayan, M. [1 ]
Akhan, S. C. [2 ]
Aygen, B. [3 ]
Koruk, S. Tekin [4 ]
Mistik, R. [5 ]
Demirturk, N. [6 ]
Ural, O. [7 ]
机构：
[1] Kocaeli Univ, Kocaeli, Izmit, Turkey
[2] Kocaeli Univ, Izmit, Kocaeli, Turkey
[3] Erciyes Univ, Sch Med, Kayseri, Turkey
[4] Harran Univ, Sanliurfa, Turkey
[5] Uludag Univ, Bursa, Turkey
[6] Afyon Kocatepe Univ, Sch Med, Afyon, Turkey
[7] Selcuk Univ, Konya, Turkey
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2014年 / 21卷
关键词：
D O I：
10.1016/j.ijid.2014.03.1367
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
64.037
引用
收藏
页码：459 / 459
页数：1
相关论文
共 50 条
  • [1] The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir
    Marks, Kristen M.
    Jacobson, Ira M.
    ANTIVIRAL THERAPY, 2012, 17 (06) : 1119 - 1131
  • [2] HCV NS3 MUTATIONS IN HCV-HIV COINFECTED AND HCV MONOINFECTED SUBJECTS
    Zamor, Philippe J.
    Rouster, Susan D.
    Sherman, Kenneth E.
    HEPATOLOGY, 2010, 52 (04) : 670A - 670A
  • [3] Macrocyclic inhibitors of HCV NS3 protease
    Venkatraman, Srikanth
    Njoroge, F. George
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (09) : 1277 - 1303
  • [4] Mutations in the natural strains of NS3 protease domain that confer resistance to anti-HCV protease inhibitors in HIV/HCV coinfected patients
    Bagaglio, S.
    Uberti-Foppa, C.
    Alagna, L.
    Lodrini, C.
    Gallotta, G.
    Galli, L.
    Dispinseri, S.
    Lazzarin, A.
    Morsica, G.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S217 - S217
  • [5] Cross Resistance to HCV NS3 Inhibitor Developing During Treatment With Peginterferon, Ribavirin and Telaprevir
    Tuncer-Ertem, Gunay
    Sayan, Murat
    Hekimoglu, Sirin
    Tulek, Necla
    KLIMIK JOURNAL, 2015, 28 (02) : 92 - 94
  • [6] Evaluating Drug Resistant Mutations to HCV NS3 Protease Inhibitors in Iranian Naive Patients
    Hashempour, Tayebeh
    Dehghani, Behzad
    Mousavi, Zahra
    Yahaghi, Maryam
    Hasanshahi, Zahra
    Moayedi, Javad
    Akbari, Tahereh
    Davarpanah, Mohammad Ali
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2020, 26 (04) : 1699 - 1710
  • [7] Identification of novel HCV NS3 protease inhibitors
    O'Meara, Jeff A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [8] Highly potent inhibitors of HCV NS3 protease
    Venables, Brian
    Sin, Ny
    Wang, Alan
    Sun, Li-Qiang
    Hernandez, Dennis
    Sheaffer, Amy
    Lee, Min
    Barry, Diana
    Friborg, Jacques
    Yu, Fei
    Knipe, Jay
    Sandquist, Jason
    Good, Andrew C.
    Mcphee, Fiona
    Meanwell, Nicholas A.
    Scola, Paul M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [9] Evolution of potent inhibitors of HCV NS3 protease
    Pessi, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U313 - U313
  • [10] Isoquinoline tripeptides as HCV NS3 protease inhibitors
    Zheng, Zhizhen Barbara
    Wang, Alan Xiangdong
    Carini, David
    Cocuzza, Anthony
    Hiebert, Sheldon
    Bowsher, Michael
    Chen, Yan
    Sit, Sing-Yuen
    Sun, Li-Qiang
    Mcphee, Fiona
    Friborg, Jacques
    Barry, Diana
    Yu, Fei
    Hernandez, Dennis
    Knipe, Jay
    Rajaman, Ramkumar
    Klei, Herbert
    Ng, Alicia
    Ma, Baoqing
    Gao, Qi
    Meanwell, Nicholas A.
    Scola, Paul M.
    D'Andrea, Stanley
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
12345